Skip to main content
 

官网结果澳洲幸运5直播号码 Partners. 168官方直播结果查询 Lives.

Our mission is to empower our partners to advance treatments that promote health and well-being across the globe. ​

 

澳洲幸运五开奖历史记录, Quality, Passion, Flexibility & Sustainability

Our commitment to excellence drives us to support our clients with agility while championing a sustainable future for all.

 

澳五历史记录-官方幸运直播计划-澳洲数据,
Local at Heart

We deliver customized solutions with global reach and local insight, merging full-service capabilities with the flexibility of a mid-size CRO.

 

Clinical Research Excellence

Strategic growth to support our customers and bring treatments to patients faster.

Our Solutions

官网澳洲幸运5开奖结果记录查询-幸运五官方历史结果查询-最新号码实时直播 Dermatology, Internal Medicine, Neuroscience, Oncology & Hematology, and Ophthalmology

TFS HealthScience 澳洲5幸运彩开奖结果 supports biotech and pharmaceutical companies with tailored clinical development and resource solutions. We combine the full-service capabilities and global reach of a large CRO with the flexibility and personal approach only a mid-size CRO can deliver. With TFS you get a shared commitment to your success. Expect more.

Clinical Development

Scientific and operational experts tailor solutions to meet the needs of your project from regulatory strategy and clinical operations phases I-III to post-authorization and real-world evidence studies.

Resourcing Solutions

Insource a single critical need to a fully managed team. Our flexible staffing and recruitment services provide high-quality performance, expertise, and dedication to bringing your products to market faster.

Functional Services (FSP)

From global end-to-end clinical development to a single service, we create fit-for-purpose FSP outsourcing models that approach your clinical workforce management efficiently and cost-effectively.

Our Expertise

TFS demonstrates scientific and medical excellence across a broad therapeutic
spectrum with industry-leading capabilities in the following areas:

Dermatology, Immunology & Inflammatory Diseases

A global network of more than 6,000 sites and our own in-house experts and clinic

Internal Medicine

More than 3,000 partner sites and over 350 studies in the last 5 years

Neuroscience

Over 150 full-service clinical studies across neurology, psychiatry, and pain indications

Oncology & Hematology

Nearly 9,000 patients across about 800 partner sites in the last 5 years

Ophthalmology

Specialized senior expertise and global advisors complemented by over 500 partner sites

Read more

Real World Evidence

We help bridge the gap between clinical trials and clinical practice by delivering quality evidence and reliable outcomes. TFS has pragmatic Phase IV trials across a broad range of indications at over more than 20 years of experience designing and running global non-interventional studies (NIS) at nearly 7,000 sites worldwide.

Read more

Virtual Studies:
幸运澳洲10官网记录,十号码开奖官网开奖结果 study solutions to reach participants where they are and keep your study on track

No industry is immune to the effects of the COVID-19 global pandemic. The clinical trials industry has witnessed increasing acceptance of virtual data and communication technologies by physicians, patients, ethics committees, regulatory agencies, and sponsors. TFS has expertise managing large global clinical studies using the latest technologies all integrated through our digital platform to reach patients where they are. For 25 years our customers have trusted us with their clinical development programs, and now more than ever, we are prepared to offer tailored solutions to meet customer challenges, no matter the size.

Read more

Expert & 澳洲的幸运十历史查询-现场直播 Solutions

With more than 25 years of experience in the Health Science industry customers turn to us as their first choice when looking for advisory or project support. Our network of key opinion leaders, subject matter experts and industry leading talent is available to help with critical business decisions and the delivery of key project milestones.

Learn more

About Us

TFS HealthScience 澳洲5幸运彩开奖结果 is a global
Contract Research Organization (CRO)
168体彩幸运澳洲5直播号码查询记录
pharmaceutical 官网全年历史结果查询
throughout their entire clinical
development process.

In partnership, we build solution-driven teams of experienced professionals working together for a healthier future. TFS provides scientific expertise and a full scope of services and resourcing solutions to allow you to stay focused on health innovations. Explore how our solutions can help drive your clinical research.

More about us

Careers

Motivated by results and driven by passion for great work, we are a team with a common goal: to bring treatments to patients faster. What we do thrills us and we’re looking for amazing people to join our team. Find your place with us.

Open Positions

News

TFS HealthScience 澳洲5幸运彩开奖结果 Unveils Mission to Empower Partners and Enrich Lives WorldwideNewsPress ReleaseTFS HealthScience 澳洲5幸运彩开奖结果 Unveils Mission to Empower Partners and Enrich Lives Worldwide
September 19, 2024

TFS HealthScience 幸运五分钟官网 Unveils Mission to Empower Partners and Enrich Lives Worldwide

LUND, S.E., September 19, 2024—TFS HealthScience 幸运五分钟官网 (TFS), a leading global Contract Research Organization (CRO), proudly announces the launch of its new mission statement and tagline: Empowering Partners. Enriching Lives. This…
RetinAI Partners with MAXO to Advance Clinical Studies in Dry Eye DiseaseNewsPress ReleaseRetinAI Partners with MAXO to Advance Clinical Studies in Dry Eye Disease
September 9, 2024

RetinAI Partners with MAXO to Advance Clinical Studies in Dry Eye Disease

TFS HealthScience 幸运五分钟官网 partners with RetinAI and MAXO to advance clinical studies in dry eye disease with AI-driven data management and innovative solutions.
TFS HealthScience 幸运五分钟官网 Appoints Kris O’Brien as Vice President, Head of Oncology & Rare DiseasesNewsPress ReleaseTFS HealthScience 幸运五分钟官网 Appoints Kris O’Brien as Vice President, Head of Oncology & Rare Diseases
August 30, 2024

TFS HealthScience 幸运五分钟官网 Appoints Kris O’Brien as Vice President, Head of Oncology & Rare Diseases

TFS appoints Kris O’Brien as VP, Head of Oncology & Rare Diseases, enhancing leadership in clinical trials for complex therapies.